KELUN PHARMA(SZ:002422) Jing Ji Guan Cha Wang·2025-05-18 14:33Core Viewpoint - The chairman of Kelun Pharmaceutical, Liu Gexin, is leveraging his personal brand to promote anti-aging products, marking his fourth entrepreneurial venture, with a focus on the health sector and the potential for rapid monetization through personal branding [2][4]. Group 1: Personal Branding and Marketing Strategy - Liu Gexin's personal brand is being positioned as the first entrepreneur IP in the pharmaceutical industry, aiming to break through traditional marketing barriers [2][3]. - The marketing materials released so far lack entertainment and scenario-based expressions, making it difficult to reach a broader audience [3]. - The anti-aging product, Ergothioneine capsules, priced at 1499 yuan per bottle, is a key focus, with its antioxidant properties being heavily marketed [3][4]. Group 2: Business Performance and Market Potential - Kelun Pharmaceutical reported a revenue decline to 4.39 billion yuan, a year-on-year decrease of 29.4%, with net profit dropping over 43% to 580 million yuan [4]. - The aging population in China presents a significant growth opportunity in the anti-aging market, which is expected to become one of the fastest-growing sectors in the silver economy [4][5]. - Kelun Yongnian Health is not limited to Ergothioneine capsules but is also developing a range of other anti-aging active molecules and health products, with over ten raw materials in production or development [5].